Study suggests daily aspirin supplement may reduce risk of breast cancer

LONDON A study published Thursday in the journal Breast Cancer Research suggested that a daily aspirin regimen may help reduce the risk of breast cancer, though there were no similar associations in other non-steroidal anti-inflammatory drugs.

“Breast cancer risk was not significantly associated with NSAID use, but daily aspirin use was associated with a modest reduction in [estrogen-receptor positive] breast cancer,” the authors concluded. “Our results provide support for further evaluating relationships by NSAID type and breast cancer subtype.”